 |
Video: What is a Stock Split?
|
 |
NanoViricides, Inc. is a development stage company, which is creating special purpose nanomaterials for antiviral therapy. Co.'s novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Its lead drug candidate is NV-CoV-2 (API NV-387) for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. Its other advanced candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 is its nanoviricide drug candidate for COVID-19 containing the nanoviricide API, NV-387. NV-CoV-2-R is its other drug candidate for COVID-19, which is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. According to our NNVC split history records, NanoViricides has had 1 split. | |
 |

NanoViricides (NNVC) has 1 split in our NNVC split history database. The split for NNVC took place on September 24, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of NNVC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as NanoViricides conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the NNVC split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NanoViricides shares, starting with a $10,000 purchase of NNVC, presented on a split-history-adjusted basis factoring in the complete NNVC split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/21/2015 |
|
End date: |
07/18/2025 |
|
Start price/share: |
$30.20 |
|
End price/share: |
$1.68 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.44% |
|
Average Annual Total Return: |
-25.09% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$556.41 |
|
Years: |
10.00 |
|
|
 |
Date |
Ratio |
09/24/2019 | 1 for 20 |
|
 |